Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Hampl, H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 55 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hampl, H
      What speaks in favor of a complete correction of renal anemia? Nephrology Workshop Berlin, October 10, 1998

      CLINICAL NEPHROLOGY
    2. Sommerburg, O; Grune, T; Hampl, H; Riedel, E; Ehrich, JHH; Siems, WG
      Does treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialysis patients?

      CLINICAL NEPHROLOGY
    3. Ludat, K; Sommerburg, O; Grune, T; Siems, WG; Riedel, E; Hampl, H
      Oxidation parameters in complete correction of renal anemia

      CLINICAL NEPHROLOGY
    4. Paulitschke, M; Ludat, K; Riedel, E; Hampl, H
      Long-term effects of rhEPO therapy on erythrocyte rheology in dialysis patients with different target hematocrits

      CLINICAL NEPHROLOGY
    5. Ludat, K; Paulitschke, M; Riedel, E; Hampl, H
      Complete correction of renal anemia by recombinant human erythropoietin

      CLINICAL NEPHROLOGY
    6. Riedel, E; Nundel, M; Wendel, G; Hampl, H
      Amino acid and alpha-keto acid metabolism depends on oxygen availability in chronic hemodialysis patients

      CLINICAL NEPHROLOGY
    7. Hampl, H; Berweck, S; Ludat, K; Fischer, HC; Hertel, J
      How can hemodialysis-associated hypotension and dialysis-induced symptoms be explained and controlled - particularly in diabetic and arterioscleroticpatients?

      CLINICAL NEPHROLOGY
    8. Berweck, S; Hennig, L; Sternberg, C; Dingerkus, H; Ludat, K; Hampl, H
      Cardiac mortality prevention in uremic patients - Therapeutic strategies with particular attention to complete correction of renal anemia

      CLINICAL NEPHROLOGY
    9. Hampl, H
      Why correct renal anemia completely?

      CLINICAL NEPHROLOGY
    10. Hampl, H; Berweck, S; Lange, D; Hennig, L
      Prevention of cardiac morbidity and mortality in uremics: therapeutic strategies with especially attention to complete correction of renal anemia

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    11. Hampl, H; Steinmuller, T; Frohling, P; Naoum, C; Leder, K; Stabell, U; Schnoy, N; Jehle, PM
      Long-term results of total parathyroidectomy without autotransplantation in patients with and without renal failure - An argument for total parathyroidectomy alone

      MINERAL AND ELECTROLYTE METABOLISM
    12. Hampl, H
      How can hemodialysis-associated hypotension be explained and controlled - particular in diabetic and arteriosclerotic patients?

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    13. Hampl, H
      Untitled

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    14. Hampl, H
      Reasons for a complete correction of renal anemia. Evaluation summary

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    15. Sommerburg, O; Grune, T; Hampl, H; Riedel, E; Ehrich, JHH; Siems, WG
      Does the treatment of renal anaemia with recombinant erythropoetin influence oxidative stress in hemodialysed patients?

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    16. Ludat, K; Sommerburg, O; Grune, T; Siems, WG; Riedel, E; Hampl, H
      Parameters indicating oxidative stress after complete correction of renal anemia

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    17. Paulitschke, M; Ludat, K; Riedel, E; Hampl, H
      Long-term effects of rhEPO therapy on theologic properties of blood from patients with chronic renal failure in dependence on hematocrit

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    18. Ludat, K; Paulitschke, M; Riedel, E; Hampl, H
      Rheological parameters before and after extracorporeal circulation in long-time hemodialysis patients

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    19. Riedel, E; Nundel, M; Wendel, G; Hampl, H
      Amino acid and alpha-keto acid metabolism of long-term hemodialysis patients depends from oxygene availability

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    20. HAMPL H
      DEVELOPMENT OF HIV TESTING - INTRODUCTION

      Infusionstherapie und Transfusionsmedizin
    21. SOMMERBURG O; GRUNE T; HAMPL H; RIEDEL E; VANKUIK FJMG; EHRICH JHH; SIEMS WG
      DOES LONG-TERM TREATMENT OF RENAL ANEMIA WITH RECOMBINANT ERYTHROPOIETIN INFLUENCE OXIDATIVE STRESS IN HEMODIALYZED PATIENTS

      Nephrology, dialysis, transplantation
    22. JANISCH T; PREISER W; BERGER A; MIKULICZ U; THOMA B; HAMPL H; DOERR HW
      EMERGING VIRAL PATHOGENS IN LONG-TERM EXPATRIATES(I) - HEPATITIS-E VIRUS

      TM & IH. Tropical medicine & international health
    23. HAMPL H; PAULITSCHKE M; LERCHE D; FISCHER H; RIEDEL E
      IMPROVED RHEOLOGY OF THE NEWLY GENERATED RBC POPULATION AS A RESULT OF RHERYTHTOPOEITIN-THERAPY (RHEPO)

      Journal of the American Society of Nephrology
    24. HAMPL H; STEINMULLER T; NAOUM C; LEDER K; STABELL U
      AN ARGUMENT FOR TOTAL PARATHYREOIDEKTOMY (TPTX) ALONE - RECURRENT 2NDHYPERPARATHYROIDISM (HPT)

      Journal of the American Society of Nephrology
    25. HAMPL H; STABELL U; STEINMULLER T; GAJAO E
      GROWTH-HORMONE THERAPY IN AN UREMIC ADOLESCENT AFTER PARATHYREOIDECTOMY (PTX) WITHOUT MEASURABLE PARATHORMON (PTH) - CASE-REPORT

      Journal of the American Society of Nephrology
    26. HUNT JC; GOLDEN AM; LUND JK; GURTLER LG; ZEKENG L; OBIANG J; KAPTUE L; HAMPL H; VALLARI A; DEVARE SG
      ENVELOPE SEQUENCE VARIABILITY AND SEROLOGIC CHARACTERIZATION OF HIV TYPE-1 GROUP-O ISOLATES FROM EQUATORIAL-GUINEA

      AIDS research and human retroviruses
    27. BRENNAN CA; HACKETT J; ZEKENG L; LUND JK; VALLARI AS; HICKMAN RK; GURTLER L; KAPTUE L; VONOVERBECK J; HAMPL H; DEVARE SG
      SEQUENCE OF GP41(ENV) IMMUNODOMINANT REGION OF HIV TYPE-1 GROUP-O FROM WEST CENTRAL-AFRICA

      AIDS research and human retroviruses
    28. PROHASZKA Z; NEMES J; HIDVEGI T; TOTH FD; KEREKES K; ERDEI A; SZABO J; UJHELYI E; THIELENS N; DIERICH MP; SPATH P; GHEBREHIWET B; HAMPL H; KISS J; ARLAUD G; FUST G
      2 PARALLEL ROUTES OF THE COMPLEMENT-MEDIATED ANTIBODY-DEPENDENT ENHANCEMENT OF HIV-1 INFECTION

      AIDS
    29. ZEKENG L; SIMA JO; HAMPL H; NDEMESOGO JM; NTUTUMU J; SIMA V; DEVARE S; KAPTUE L; GURTLER L
      UPDATE ON HIV-1 GROUP-O INFECTION IN EQUATORIAL-GUINEA, CENTRAL-AFRICA

      AIDS
    30. TRIPPLER M; HAMPL H; GOERGEN B; SPIES U; KNOLLE P; GRIMM B; ZUMBUSCHENFELDE KHM; GERKEN G
      LIGASE CHAIN-REACTION (LCR(R)) ASSAY FOR SEMIQUANTITATIVE DETECTION OF HBV DNA IN MONONUCLEAR LEUKOCYTES OF PATIENTS WITH CHRONIC HEPATITIS-B

      Journal of viral hepatitis
    31. HAMPL H; FUCHS M; RIEDEL E; BOSCH J
      IMPROVEMENT OF POLYAMINE OVERLOAD BY TOTAL CORRECTION OF ANEMIA USINGRHEPO IN HEMODIALYSIS (HD) PATIENTS

      Journal of the American Society of Nephrology
    32. RIEDEL E; HAMPL H; NUNDEL M; BOSCH J
      TOTAL CORRECTION OF RENAL ANEMIA IMPROVES MALNUTRITION AND AMINO-ACID(AA) METABOLISM IN HEMODIALYSIS (HD) PATIENTS

      Journal of the American Society of Nephrology
    33. HAMPL H; STEINMULLER T; FROHLING P; STABELL U; FREI U; NEUHAUS P; BOSCH J
      LONG-TERM RESULTS OF TOTAL PARATHYROIDECTOMY (T-PTX) IN PATIENTS WITHAND WITHOUT RENAL DISEASES

      Journal of the American Society of Nephrology
    34. RIEDEL E; HAMPL H; STEUDLE V; NUNDEL M
      CALCIUM ALPHA-KETOGLUTARATE ADMINISTRATION TO MALNOURISHED HEMODIALYSIS-PATIENTS IMPROVES PLASMA ARGININE CONCENTRATIONS

      Mineral and electrolyte metabolism
    35. KAPPRELL HP; MICHEL G; HAMPL H; BONINO F; ESTEBAN JI
      DEMONSTRATION OF SPECIFIC DETECTION OF ANTI-HCV IGM CORE ANTIBODIES

      Journal of virological methods
    36. RIEDEL E; NUNDEL M; HAMPL H
      ALPHA-KETOGLUTARATE APPLICATION IN HEMODI ALYSIS-PATIENTS IMPROVES AMINO-ACID-METABOLISM

      Nephron
    37. HAMPL H; FISCHER HC; WENDEL G; RIEDEL E
      RED-BLOOD-CELL (RBC) RHEOLOGY IMPROVES WITH HIGH-DOSE EPO THERAPY IN HEMODIALYSIS (HD) PATIENTS

      Journal of the American Society of Nephrology
    38. RIEDEL E; FUCHS M; HAMPL H; FISCHER HC
      HEMODIALYSIS (HD) PATIENTS WITH COMPLETE CORRECTION OF RENAL ANEMIA BY RHEPO - POLYAMINES

      Journal of the American Society of Nephrology
    39. LYNCH R; OFLYNN N; CRYAN B; HAMPL H; OPSTELTEN B
      HEPATITIS-E IN IRELAND

      European journal of clinical microbiology & infectious diseases
    40. HUNT JC; GOLDEN AM; VALLARI A; HAMPL H; GURTLER L; ZEKENG L; KAPTUE L; DEVARE SG
      MOLECULAR AND SEROLOGIC CHARACTERIZATION OF 4 HIV-I GROUP-O SERA FROMEQUATORIAL-GUINEA

      AIDS research and human retroviruses
    41. POHJANPELTO P; EBELING F; RASI V; HAMPL H
      HEPATITIS-E VIRUS - NO EVIDENCE OF PARENTERAL TRANSMISSION IN FINLAND

      Thrombosis and haemostasis
    42. HAMPL H; KAPPRELL HP; SAWITZKY D; WILSKE W; GURTLER L
      DETECTION OF SPECIFIC HUMAN-IMMUNODEFICIENCY-VIRUS IGM ANTIBODIES

      Medical microbiology and immunology
    43. HAMPL H; SAWITZKY D; STOFFLERMEILICKE M; GROH A; SCHMITT M; EBERLE J; GURTLER L
      FIRST CASE OF HIV-1 SUBTYPE-0 INFECTION IN GERMANY

      Infection
    44. SYLVAN SPE; HELLSTROM UB; HAMPL H; KAPPRELL HP; TROONEN H
      HEPATITIS-E IN PATIENTS WITH CHRONIC AUTOIMMUNE LIVER-DISEASE

      JAMA, the journal of the American Medical Association
    45. FUCHS M; RIEDEL E; HAMPL H; WENDEL G
      POLYAMINES IN RED-BLOOD-CELLS (RBC) AND PLASMA OF HEMODIALYSIS (HD) PATIENTS

      Kidney international
    46. FUCHS M; RIEDEL E; HAMPL H; WENDEL G
      POLYAMINES IN RED-BLOOD-CELLS (RBC) AND PLASMA OF HEMODIALYSIS (HD) PATIENTS

      Kidney international
    47. CLAEYS H; VERHAERT H; LIANG Z; VERMYLEN C; OPSTELTEN R; HAMPL H
      NEW TOOLS FOR HCV CONFIRMATION

      Vox sanguinis
    48. KAPPRELL HP; MAJNAK A; MEDGYESI GA; SZABO JE; MICHEL G; ALBRECHT M; HEYERMANN H; HAMPL H; TROONEN H
      HCV CORE IGM AND IGG ANTIBODIES IN BLOOD-DONORS

      Vox sanguinis
    49. RIEDEL E; HAMPL H
      CORRECTION OF AMINO-ACID-METABOLISM DURING RHEPO THERAPY IN HEMODIALYSIS-PATIENTS RESULTS FROM A BETTER OXYGEN AVAILABILITY

      Nephron
    50. HAMPL H; STEINMULLER T; STABELL U; SCHNOY N; DELLING G
      TOTAL PARATHYROIDECTOMY (TPX) WITHOUT IMMEDIATE AUTOTRANSPLANTATION (AT) IN 2(0)HYPERPARATHYROIDISM (HPT)

      Journal of the American Society of Nephrology
    51. STABELL U; STEINMULLER T; HAMPL H
      NONINVASIVE ISOTOPE IMAGING IN RECURRENT HYPERPARATHYROIDISM (RHPT) -HIGH-ACCURACY THROUGH NEW IMAGING TECHNIQUES

      Journal of the American Society of Nephrology
    52. BAUMGARTEN K; CHIEWSILP P; GILCHER R; GURTLER L; HAMPL H; HENRARD D; HOLZBERGER G; JULLIEN AM; KUHNL P; MATTHES G; POSCHMANN A
      COMMENTS ON HIV-ANTIGEN SCREENING IN DONA TED BLOOD UNITS

      Infusionstherapie und Transfusionsmedizin
    53. GOERGEN B; SPIES U; TRIPPLER M; SZEPANSKI S; BUSCHENFELDE KHMZ; HAMPL H; GERKEN G
      SEMIQUANTITATIVE DETECTION OF HBV DNA IN LYSATES OF MONONUCLEAR LEUKOCYTES USING THE LIGASE CHAIN-REACTION (LCR)

      Hepatology
    54. HIDVEGI T; PROHASZKA Z; UJHELYI E; THIELENS NM; DIERICH MP; HAMPL H; ARLAUD G; NAGY K; FUST G
      STUDIES ON THE MECHANISM OF COMPLEMENT-MEDIATED INHIBITION OF ANTIBODY-BINDING TO HIV GP41

      Clinical and experimental immunology
    55. RIEDEL E; HAMPL H; NUNDEL M; FARSHIDFAR G
      ESSENTIAL BRANCHED-CHAIN AMINO-ACIDS AND ALPHA KETOANALOGS IN HEMODIALYSIS-PATIENTS

      Nephrology, dialysis, transplantation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 02:56:23